3//SEC Filing
BLACK HILL INVESTMENT ADVISORS LLC 3
Accession 0001209191-03-029664
CIK 0001110009other
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 8:44 PM ET
Size
8.2 KB
Accession
0001209191-03-029664
Insider Transaction Report
Form 3
BLACK HILL INVESTMENT ADVISORS LLC
10% Owner
Holdings
- (indirect: By managed account)
Warrant to purch 156,379 shares Series A Convert Pref Stock
From: 2003-10-29Exp: 2005-12-31→ Common Stock, $0.001 par value (1,563,790 underlying) - 877,500(indirect: By managed account)
Common Stock, $0.001 par value
- (indirect: By managed account)
222,222 shares of Series A Convertible Preferred Stock
From: 2003-10-29→ Common Stock, $0.001 par value (2,222,220 underlying) - 30,000(indirect: By Black Hill Research Partners, L.P.)
Common Stock, $0.001 par value
Footnotes (5)
- [F1]The reporting persons disclaim beneficial ownership of these securities except to the extent of their respective pecuniary interests therein.
- [F2]The shares are held by Black Hill Research Partners, L.P. Black Hill Investment Advisors, L.L.C. does not beneficially own nor have a pecuniary interest in these shares. Sangbum Kim and Richard Billy disclaim beneficial ownership of the shares except to the extent of their respective pecuniary interests therein.
- [F3]10 for 1
- [F4]$22.50 per share
- [F5]None
Documents
Issuer
GENAISSANCE PHARMACEUTICALS INC
CIK 0001110009
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001268554
Filing Metadata
- Form type
- 3
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 8:44 PM ET
- Size
- 8.2 KB